Portugal · Health startup

BAMandBOO

At BAMandBOO, we harness the unique biodiversity of the Azores to create science-backed, sustainable skincare that seamlessly blends nature's purity with cutting-edge innovation.

Funding reportedLast round: Seed

HealthLisbon, Portugal

About BAMandBOO

At BAMandBOO, we harness the unique biodiversity of the Azores to create science-backed, sustainable skincare that seamlessly blends nature's purity with cutting-edge innovation.

Our formulations are designed for those seeking effective skincare and a deeper connection to nature, promoting holistic well-being through a commitment to transparency, efficiency, and environmental responsibility. OUR MANIFESTO We're hostages of nature's cosmic timetable. We can't postpone, rewind, or control, not now, not ever. The time ticking through the fleeting seasons, embracing our whole lives outside ourselves. Until one day, one time, we let our inner rhythm align. Our bodies blooming, our thoughts soothing, our mighty emotions gaining space, and our lost peace climbing back to us. Allowing us to let go in nature feeling more grounded than ever before.

What company datasets say BAMandBOO raised

Funding, as reported

Reported in all500kin the source's currency
Last roundSeed
Last round dateJul 2024
Investors listed1

The company, in detail

What they build

Known for

beauty productsconsumersmanufacturinghair careinformation technology & servicesclimate neutralalgae skincarecosmeticshyaluronic acidand game manufacturingazorean botanical extractsclean beautysustainable beautybeautyb2cazorean green tea

Built with from their website

Google MapsAmazon CloudFrontHREF LangPaypalGoogle CloudKlaviyoClarity SDMYouTubeGoogle WorkspaceCloudFlare

+8 more

Viewport MetaWebflow HostingGoogle Cloud HostingGoogle MeetGoogle Font APIApple PayMySQLMobile Friendly

Sector
Health
Industry code
NAICS 33993, 325620, SIC 2844
Region
Lisbon

Health in Portugal

Startups like it

Is this your company?

Add your raise, your deck and your story, and put BAMandBOO in front of investors. Or tell us what we have wrong.